Question · Q4 2025
Nicole Deblase asked about the Medline relationship, their commitment, the broader healthcare opportunity, and the sales force's aggressive pursuit of new customers. She also inquired about the expected ramp of next-gen systems and the revenue cadence for the first half versus the second half of fiscal year 2026.
Answer
Rick Cohen (CEO, Symbotic) detailed the year-long Medline engagement, highlighting Symbotic's system capabilities in item handling, accuracy, and product sequencing for hospitals. He noted Medline's extensive warehouses and Symbotic's increased sales force (5-6 new hires in six months) and aggressive marketing post-deployment improvements. Izzy Martins (CFO, Symbotic) confirmed a less pronounced revenue increase in Q4, Q1, and Q2, with a more significant ramp towards the end of fiscal year 2026, driven by next-gen system signings.
Ask follow-up questions
Fintool can predict
SYM's earnings beat/miss a week before the call